DARAXONRASIB

UNII:	B6T47Y2UAP
Formula:	C₄₄H₅₈N₈O₅S
Preferred Substance Name:	DARAXONRASIB
InChIKey:	FVICRBSEYSHKFY-JYQNNKODSA-N

2765081-21-6
(1S,2S)-N-((12M,4S,63S)-11-ETHYL-12-(2-((1S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-11H-8-OXA-1(5,3)-INDOLA-6(1,3)-(1,2)DIAZINANA-2(4,2)-(1,3)THIAZOLACYCLOUNDECAPHAN-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
CYCLOPROPANECARBOXAMIDE, N-((2R,14S,18S)-1-ETHYL-18,19,20,21-TETRAHYDRO-2-(2-((1S)-1-METHOXYETHYL)-5-(4-METHYL-1-PIPERAZINYL)-3-PYRIDINYL)-25,25-DIMETHYL-15,22-DIOXO-17H-5,3-((4,2)-ENDO-THIAZOLOPROPANO(1,3)-ENDO-PYRIDAZINOMETHANOXYPROPANO)-1H-INDOL-14-YL)-2-METHYL-, (1S,2S)-
DARAXONRASIB [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DARAXONRASIB

Synonyms and Mappings

Resources